[HTML][HTML] Dashboards in health care settings: protocol for a scoping review

D Helminski, JE Kurlander, AD Renji… - JMIR Research …, 2022 - researchprotocols.org
Background Health care organizations increasingly depend on business intelligence tools,
including “dashboards,” to capture, analyze, and present data on performance metrics. Ideally…

Opioid policy and chronic pain treatment access experiences: A multi-stakeholder qualitative analysis and conceptual model

S Slat, A Yaganti, J Thomas, D Helminski… - Journal of Pain …, 2021 - Taylor & Francis
Purpose Patients on long-term opioid therapy (LTOT) for pain have difficulty accessing primary
care clinicians who are willing to prescribe opioids or provide multimodal pain treatment. …

Prescribing of Proton Pump Inhibitors for Prevention of Upper Gastrointestinal Bleeding in US Outpatient Visits

…, CR Richardson, D Helminski - Clinical …, 2024 - cghjournal.org
Dr. Kurlander was supported by the Department of Veterans Affairs’ QUERI program Grant#
20-27 025 and NIDDK K23 DK118179. The views represented in this manuscript do not …

Association of antisecretory drugs with upper gastrointestinal bleeding in patients using oral anticoagulants: a systematic review and meta-analysis

…, GD Barnes, A Fisher, JJ Gonzalez, D Helminski… - The American journal of …, 2022 - Elsevier
Background The role of antisecretory drugs for the prevention of upper gastrointestinal bleeding
in patients using anticoagulants is unclear. We investigated this question in a systematic …

[HTML][HTML] Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy …

JE Kurlander, D Helminski, M Lanham… - Implementation Science …, 2022 - Springer
Background The concomitant use of anticoagulant and antiplatelet medications increases
the risk of upper gastrointestinal (GI) bleeding. Two underused evidence-based practices (…

Trials of dual antiplatelet therapy after percutaneous coronary intervention lack strategies to ensure appropriate gastroprotection

…, GD Barnes, D Sukul, D Helminski… - Official journal of the …, 2021 - journals.lww.com
METHODS: A methodological review of randomized trials comparing varying durations of
DAPT after percutaneous coronary intervention. RESULTS: Among 21 trials, none …

Barriers to guideline-based use of proton pump inhibitors to prevent upper gastrointestinal bleeding

JE Kurlander, D Helminski, AN Kokaly… - The Annals of Family …, 2022 - Annals Family Med
PURPOSE Gastrointestinal (GI) bleeding is one of the most common serious adverse drug
events. Guidelines recommend proton pump inhibitor (PPI) gastroprotection to prevent upper …

[PDF][PDF] Mo1006 QUALITATIVE ANALYSIS OF BARRIERS TO THE USE OF PPI'S FOR THE PREVENTION OF UPPER GASTROINTESTINAL BLEEDING

AN Kokaly, D Helminski, R De Vries… - …, 2020 - researchgate.net
Background: Proton pump inhibitors (PPIs) are highly effective for prevention of upper GI
bleeding (UGIB) and are recommended in high-risk patients. However, most high-risk patients …

[PDF][PDF] Dashboards in Healthcare Settings: A Scoping Review Protocol

D Helminski, JE Kurlander, AD Renji, JB Sussman… - s3.ca-central-1.amazonaws.com
Background: Healthcare organizations increasingly depend on business intelligence tools,
including “dashboards,” to capture, analyze, and present data on performance metrics. Ideally…

Trials of Dual Antiplatelet Therapy Do Not Include Evidence-Based Strategies for Gastrointestinal Bleeding Prevention

JE Kurlander, G Barnes, D Sukul, D Helminski… - Circulation, 2020 - Am Heart Assoc
Background: Proton pump inhibitors (PPIs) substantially reduce the risk of upper gastrointestinal
bleeding (GIB) and are recommended for high-risk patients by professional cardiology …